Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration

Salmena, 2008, Tenets of PTEN tumor suppression, Cell, 133, 403, 10.1016/j.cell.2008.04.013 Kim, 2006, Tumours and tremors: how PTEN regulation underlies both, Br. J. Cancer, 94, 620, 10.1038/sj.bjc.6602994 Feilotter, 1999, Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma, Br. J. Cancer, 79, 718, 10.1038/sj.bjc.6690115 Garcia, 1999, Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype, Breast Cancer Res. Treat., 57, 237, 10.1023/A:1006273516976 Depowski, 2001, Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer, Mod. Pathol., 14, 672, 10.1038/modpathol.3880371 Perren, 1999, Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast, Am. J. Pathol., 155, 1253, 10.1016/S0002-9440(10)65227-3 Saal, 2005, P.I.K.3.C.A. mutations correlate with hormone receptors node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma, Cancer Res., 65, 2554, 10.1158/0008-5472-CAN-04-3913 Suzuki, 1998, High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice, Curr. Biol., 8, 1169, 10.1016/S0960-9822(07)00488-5 Stambolic, 1998, Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN, Cell, 95, 29, 10.1016/S0092-8674(00)81780-8 Di Cristofano, 1998, Pten is essential for embryonic development and tumour suppression, Nat. Genet., 19, 348, 10.1038/1235 Stambolic, 2000, High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice, Cancer Res., 60, 3605 Podsypanina, 1999, Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proc. Natl. Acad. Sci. U. S. A, 96, 1563, 10.1073/pnas.96.4.1563 Li, 2002, Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland, Development, 129, 4159, 10.1242/dev.129.17.4159 Maehama, 2001, PTEN and myotubularin: novel phosphoinositide phosphatases, Annu. Rev. Biochem., 70, 247, 10.1146/annurev.biochem.70.1.247 Manning, 2007, AKT/PKB signaling: navigating downstream, Cell, 129, 1261, 10.1016/j.cell.2007.06.009 Yuan, 1998, Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP, Cancer Res., 58, 2196 Durkin, 2007, DLC-1: a Rho GTPase-activating protein and tumour suppressor, J. Cell Mol. Med., 11, 1185, 10.1111/j.1582-4934.2007.00098.x Lahoz, 2008, DLC1: a significant GAP in the cancer genome, Genes Dev., 22, 1724, 10.1101/gad.1691408 Healy, 2008, DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms, Mol. Carcinog., 47, 326, 10.1002/mc.20389 Wong, 2003, Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma, Cancer Res., 63, 7646 Jaffe, 2005, Rho GTPases: biochemistry and biology, Annu. Rev. Cell Dev. Biol., 21, 247, 10.1146/annurev.cellbio.21.020604.150721 Ridley, 2006, Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking, Trends Cell Biol., 16, 522, 10.1016/j.tcb.2006.08.006 Xue, 2008, DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma, Genes Dev., 22, 1439, 10.1101/gad.1672608 Holeiter, 2008, Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway, Cancer Res., 68, 8743, 10.1158/0008-5472.CAN-08-0984 Ridley, 2003, Cell migration: integrating signals from front to back, Science, 302, 1704, 10.1126/science.1092053 Scholz, 2009, DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling, J. Cell Sci., 122, 92, 10.1242/jcs.036251 Kolsch, 2008, The regulation of cell motility and chemotaxis by phospholipid signaling, J. Cell Sci., 121, 551, 10.1242/jcs.023333 Leslie, 2005, The regulation of cell migration by PTEN, Biochem. Soc. Trans., 33, 1507, 10.1042/BST0331507 Tamura, 1998, Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN, Science, 280, 1614, 10.1126/science.280.5369.1614 Sekimata, 1999, Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho, J. Biol. Chem., 274, 17757, 10.1074/jbc.274.25.17757 Ginn-Pease, 2003, Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells, Cancer Res., 63, 282 Vazquez, 2006, Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction, Cell Cycle, 5, 1523, 10.4161/cc.5.14.3005 Odriozola, 2007, Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain, J. Biol. Chem., 282, 23306, 10.1074/jbc.M611240200 Li, 2001, Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice, BMC Mol. Biol., 2, 2, 10.1186/1471-2199-2-2 Dourdin, 2008, Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis, Cancer Res., 68, 2122, 10.1158/0008-5472.CAN-07-5727 Liao, 2008, Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function, Cancer Res., 68, 7718, 10.1158/0008-5472.CAN-08-2042 Weng, 1999, PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death, Cancer Res., 59, 5808 Yuan, 2003, DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity, Oncogene, 22, 445, 10.1038/sj.onc.1206064 Funamoto, 2002, Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis, Cell, 109, 611, 10.1016/S0092-8674(02)00755-9 Iijima, 2002, Tumor suppressor PTEN mediates sensing of chemoattractant gradients, Cell, 109, 599, 10.1016/S0092-8674(02)00745-6 Wessels, 2007, PTEN plays a role in the suppression of lateral pseudopod formation during Dictyostelium motility and chemotaxis, J. Cell Sci., 120, 2517, 10.1242/jcs.010876 Liliental, 2000, Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases, Curr. Biol., 10, 401, 10.1016/S0960-9822(00)00417-6 Suzuki, 2003, Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination, J. Exp. Med., 197, 657, 10.1084/jem.20021101 Lacalle, 2004, P.T.E.N. regulates motility but not directionality during leukocyte chemotaxis, J. Cell Sci., 117, 6207, 10.1242/jcs.01545 Nishio, 2007, Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1, Nat. Cell Biol., 9, 36, 10.1038/ncb1515 Raftopoulou, 2004, Regulation of cell migration by the C2 domain of the tumor suppressor PTEN, Science, 303, 1179, 10.1126/science.1092089 Yam, 2006, Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression, Cancer Res., 66, 8367, 10.1158/0008-5472.CAN-05-2850 Qian, 2007, Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities, Proc. Natl. Acad. Sci. U. S. A., 104, 9012, 10.1073/pnas.0703033104 Kim, 2003, SAM domains: uniform structure, diversity of function, Trends Biochem. Sci., 28, 625, 10.1016/j.tibs.2003.11.001 Li, 2005, Regulation of PTEN by Rho small GTPases, Nat. Cell Biol., 7, 399, 10.1038/ncb1236